Brief: Catalyst Pharmaceuticals Q2 Revenue USD 122.7 Million Vs. IBES Estimate USD 111.9 Million

Catalyst Pharmaceuticals

07/08/2024 21:12

Aug 07 (Reuters) - Catalyst Pharmaceuticals Q2 adjusted net income USD 69.6
million vs. IBES estimate USD 32.8 million.
* Q2 operating income USD 54.2 million vs. IBES estimate USD 36.4 million
* Q2 net income USD 40.8 million
* outlook FY revenue USD 35-40 million